V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20220714 | 20169013 | 0 | 110.7 | null | 2020-09-05 | 2020-09-11 | LANREOTIDE | 02 | null | LANREOTIDE | 101248078 |
| 20220715 | 20169014 | 0 | 74 | Palliative (P) | null | 2021-03-07 | LANREOTIDE | 02 | N | LANREOTIDE | 101790058 |
| 20220745 | 20169015 | 0 | 96.6 | null | 2018-04-17 | 2019-02-28 | null | 02 | null | CAPECITABINE + MITOMYCIN | 100231340 |
| 20220747 | 20169016 | 0 | null | Palliative (P) | null | 2018-09-23 | null | null | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101606636 |
| 20220778 | 20169017 | 0 | 69.8 | Curative (C) | 2018-07-30 | 2018-08-13 | LENVATINIB | 02 | N | LENVATINIB | 100854304 |
| 20220784 | 20169018 | 0 | null | Palliative (P) | 2015-12-13 | 2016-05-29 | LENVATINIB | 02 | N | LENVATINIB | 100981795 |
| 20220796 | 20169019 | 0 | 95.3 | Curative (C) | null | 2018-07-14 | LENVATINIB | 02 | N | LENVATINIB | 100424166 |
| 20220800 | 20169020 | 0 | null | null | 2019-05-01 | 2020-01-21 | LENVATINIB | 02 | null | LENVATINIB | 100941969 |
| 20220820 | 20169021 | 0 | 65.6 | null | 2018-11-22 | 2018-12-02 | LANREOTIDE | 02 | null | LANREOTIDE | 101817856 |
| 20220833 | 20169022 | 0 | 71.5 | null | 2021-03-27 | 2021-04-24 | LENVATINIB | 02 | null | LENVATINIB | 101740835 |
| 20220842 | 20169023 | 0 | 89.25 | null | 2017-09-27 | 2019-11-10 | LANREOTIDE | 02 | null | LANREOTIDE | 100089777 |
| 20220846 | 20169024 | 0 | null | Palliative (P) | 2018-10-26 | 2018-12-05 | LENVATINIB | 02 | N | LENVATINIB | 100709450 |
| 20220864 | 20169025 | 1.51 | 71 | Palliative (P) | 2018-11-15 | 2018-11-20 | LANREOTIDE | 02 | N | LANREOTIDE | 100086352 |
| 20220875 | 20169026 | 0 | 96.95 | Curative (C) | 2019-10-10 | 2019-11-02 | LENVATINIB | 02 | N | LENVATINIB | 100082521 |
| 20220877 | 20169027 | 0 | 71 | Palliative (P) | null | 2017-11-07 | null | N | N | HCX | 100992867 |
| 20220896 | 20169028 | 0 | 70 | Palliative (P) | null | 2016-10-21 | LANREOTIDE | 02 | N | LANREOTIDE | 100136464 |
| 20220929 | 20169030 | 0 | null | null | 2018-02-02 | 2018-02-21 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | null | FLUOROURACIL + MITOMYCIN | 100099103 |
| 20221057 | 20169039 | 0 | 93.6 | 03 | 2019-10-25 | 2019-12-21 | null | 02 | Y | CAPECITABINE + MITOMYCIN | 100264853 |
| 20221104 | 20169044 | 1.75 | 0 | null | 2017-04-04 | 2017-04-18 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100266547 |
| 20221160 | 20169052 | 0 | 0 | Palliative (P) | 2020-04-16 | 2020-05-11 | OXALIPLATIN + MDG + PANITUMUMAB | null | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100619488 |
| 20221295 | 20169055 | 0 | 83.2 | Curative (C) | 2018-08-12 | 2018-09-25 | LANREOTIDE | 02 | Y | LANREOTIDE | 101301235 |
| 20221300 | 20169057 | 0 | 71.9 | null | 2019-06-08 | 2019-06-22 | null | N | N | HCX | 101375907 |
| 20221377 | 20169060 | 0 | 92.7 | null | null | 2018-05-06 | Capecitabine + Mitomycin | 02 | null | CAPECITABINE + MITOMYCIN | 100325903 |
| 20221657 | 20169067 | 0 | 61.2 | Palliative (P) | 2019-04-19 | 2019-05-29 | HCX | N | N | HCX | 101042109 |
| 20221711 | 20169068 | 0 | 0 | Palliative (P) | 2017-08-28 | 2018-01-14 | Panitumumab +Oxaliplatin +MdG | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100034054 |
| 20221782 | 20169073 | 0 | null | Palliative (P) | 2018-10-17 | 2018-11-17 | Panitumumab +Oxaliplatin +MdG | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100325734 |
| 20221814 | 20169074 | 0 | null | Palliative (P) | 2019-04-11 | 2019-04-18 | null | 02 | N | FLUOROURACIL + MITOMYCIN | 101047669 |
| 20221853 | 20169075 | 0 | 0 | null | 2018-06-11 | 2018-06-25 | LENVATINIB | 02 | null | LENVATINIB | 100772706 |
| 20221870 | 20169076 | 0 | null | Palliative (P) | 2017-05-01 | 2018-04-15 | null | 02 | N | LANREOTIDE | 100876326 |
| 20221892 | 20169079 | 1.74 | 114 | null | 2017-05-27 | 2017-06-05 | null | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100661654 |
| 20221897 | 20169080 | 1.63 | 110.4 | Curative (C) | 2020-11-17 | 2020-11-20 | Capecitabine + Mitomycin | 02 | N | CAPECITABINE + MITOMYCIN | 100382815 |
| 20221909 | 20169081 | null | null | Palliative (P) | null | 2016-11-17 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | FLUOROURACIL + MITOMYCIN | 100923218 |
| 20221911 | 20169082 | null | null | null | 2015-10-26 | 2016-04-11 | HCX (Cape + Cisp + Tras) - Main | 02 | null | HCX | 100526766 |
| 20221945 | 20169083 | null | null | Palliative (P) | 2019-01-16 | 2019-01-16 | null | 02 | N | LANREOTIDE | 100034724 |
| 20221947 | 20169084 | 0 | 81 | null | 2014-04-04 | 2014-04-04 | LANREOTIDE | 02 | null | DOXORUBICIN EMBOLISATION | 100612789 |
| 20221977 | 20169085 | null | null | null | 2015-10-25 | 2016-07-27 | null | N | null | LENVATINIB | 100127787 |
| 20222025 | 20169087 | 0 | 65 | null | 2017-03-17 | 2019-05-10 | null | 02 | null | LENVATINIB | 100851418 |
| 20222039 | 20169088 | 1.63 | 76.3 | null | null | 2019-01-24 | Capecitabine + Mitomycin | 02 | null | CAPECITABINE + MITOMYCIN | 101227063 |
| 20222059 | 20169091 | 0 | 81.5 | 03 | 2018-08-20 | 2018-08-25 | null | 02 | null | LENVATINIB | 101167547 |
| 20222084 | 20169092 | 0 | 83.8 | null | 2017-08-31 | 2017-09-11 | null | 02 | null | LANREOTIDE | 100449058 |
| 20222102 | 20169093 | 1.58 | 80 | null | 2017-10-30 | 2017-11-08 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100246224 |
| 20222104 | 20169094 | 0 | 55 | Curative (C) | 2017-04-11 | 2017-08-27 | Capecitabine + Mitomycin | 02 | N | CAPECITABINE + MITOMYCIN | 100259480 |
| 20222134 | 20169095 | 0 | 57.3 | Palliative (P) | 2018-04-29 | 2018-04-30 | null | 02 | N | FLUOROURACIL + MITOMYCIN | 101074999 |
| 20222145 | 20169096 | null | null | null | 2016-07-20 | 2016-08-22 | null | 02 | null | HCX | 101584749 |
| 20222171 | 20169097 | 0 | null | null | 2019-11-12 | 2020-01-05 | Capecitabine + Mitomycin | 02 | null | CAPECITABINE + MITOMYCIN | 101213029 |
| 20222205 | 20169099 | 0 | 70 | Curative (C) | 2017-07-04 | 2017-07-05 | LENVATINIB | 02 | Y | LENVATINIB | 101159359 |
| 20222223 | 20169101 | 0 | null | Curative (C) | 2014-04-27 | 2018-09-21 | null | N | Y | HCX | 101633686 |
| 20222275 | 20169103 | 0 | 55.2 | null | 2019-05-25 | 2019-06-27 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101611951 |
| 20222300 | 20169104 | 0 | 42.3 | null | 2016-11-29 | 2016-12-06 | null | 02 | null | CAPECITABINE + MITOMYCIN | 101322529 |
| 20222306 | 20169105 | 0 | 127.4 | Palliative (P) | 2017-07-08 | 2017-07-22 | Cape+Cisplatin+Trastuzumab Main | 2 | N | LANREOTIDE | 101569150 |